We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nanoparticle Vaccine Technology Introduces Immune System to a Variety of Different Coronaviruses

News   Jan 13, 2021 | Original story from Caltech

 
Nanoparticle Vaccine Technology Introduces Immune System to a Variety of Different Coronaviruses

This new vaccine prototype works by attaching many protein fragments (specifically, receptor-binding domains or RBDs) to an engineered protein-based nanoparticle. The study, in mice, showed that the vaccine induced the production of antibodies that are broadly reactive to a wide range of coronaviruses. RBDs are particularly important for a virus to be able to infect a cell, so antibodies that recognize RBDs are likely more effective at preventing bad infections. Credit: Courtesy of A. Cohen via BioRender.

 
 
Advertisement
 

RELATED ARTICLES

Deep Learning Shows How Genetic Motifs Conduct the “Music of Life”

News

Using AI and supercomputers, researchers have discovered reoccurring patterns and combinations, known as "motifs", of the four molecular building blocks A, C, G and T, connecting them to gene expression, that is, average amounts of produced proteins.

READ MORE

How the Immune System Keeps an Eye on the Brain

News

Researchers believe they have figured out how the immune system keeps tabs on what's going on in the brain.

READ MORE

Antibiotic Could Improve Outcomes in Depressed Patients With Low-Level Inflammation

News

King's College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE